Clinical trial
Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients
NCT02588937 is registered in ClinicalTrials.gov with Chong Kun Dang Pharmaceutical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients
- Lead sponsor
- Chong Kun Dang Pharmaceutical
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- June 30, 2017
- Enrollment
- 76 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.